Production of viruses in continuously growing epithelial cell lines derived from chicken gut
View Patent ↗It is provided a method for manufacturing viruses in an in vitro cell culture. The method comprising the following steps: providing a cell culture of avian epithelial cells chosen from at least one of the cell cultures deposited under deposition numbers DSM ACC3345, DSM ACC3346, DSM ACC3347, DSM ACC3348, DSM ACC3349 at Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen and Zellkulturen GmbH on Dec. 12, 2018; infecting at least some of the cells in the cell culture with virus particles; incubating the cells for a first period of time; and recovering viruses produced by the cell culture from a supernatant of the cell culture.
1. A method for manufacturing viruses in an in vitro cell culture, comprising the following steps: a) providing a cell culture of avian epithelial cells chosen from at least one of the cell cultures deposited under deposition numbers DSM ACC3345, DSM ACC3346, DSM ACC3347, DSM ACC3348, DSM ACC3349; b) infecting at least some of the cells in the cell culture with virus particles; c) incubating the cells for a first period of time; and d) recovering viruses produced by the cell culture from a supernatant of the cell culture.
2. The method according to claim 1 , wherein the viruses are viruses able to cause an infection in humans.
3. The method according to claim 1 , wherein the viruses are viruses able to cause an infection in fowl.
4. The method according to claim 1 , wherein the viruses are chosen from the group consisting of influenza virus, avian infectious bronchitis virus, avian infectious laryngotracheitis virus, avian nephritis virus, chicken anemia virus, egg drop syndrome virus, infectious bursal disease virus, Marek's disease virus, and Newcastle disease virus.
5. The method according to claim 1 , wherein the viruses are viruses belonging to the family of Orthomyxoviridae.
6. The method according to claim 1 , wherein the viruses are influenza viruses.
7. The method according to claim 6 , wherein the viruses are influenza viruses able to cause an infection in at least one of humans, fowl, seals, pigs, cattle, dogs, and horses.
8. The method according to claim 1 , wherein the step of infecting is done with 0.00001 to 10 virus particles per cell in the cell culture.
9. The method according to claim 1 , wherein the step of incubating is done at a temperature of 32° C. to 45° C.
10. The method according to claim 1 , wherein the first period of time has a duration of between 24 hours and 1 week.
11. A method for manufacturing a vaccine, comprising the following steps:
a) carrying out a method according to claim 1 to obtain a virus culture;
b) inactivating or attenuating viruses contained in the virus culture and/or fragmenting viruses contained in the virus culture to obtain an antigen solution;
c) combining the antigen solution with a carrier substance to obtain a vaccine.
12. The method according to claim 11 , wherein the virus culture and/or the antigen solution is concentrated and/or purified to obtain a processed virus culture comprising viruses in a defined concentration and/or purity and/or a processed antigen solution comprising antigens in a defined concentration and/or purity.
13. The method according to claim 11 , wherein at least two different virus cultures comprising different virus strains of the same virus are used.